Inj. Ferric carboxymaltose (fcm) vs iron Isomaltoside (iim) in anemia in pregnancy (antenatal) - a randomized controlled trial

Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1324

Full metadata record

DC Field	Value	Language
dc.contributor.author	REGNO.BJ0119006	-
dc.date.accessioned	2023-03-28T15:09:05Z	-
dc.date.available	2023-03-28T15:09:05Z	-
dc.date.issued	2022	-
dc.identifier.uri	http://localhost:8080/xmlui/handle/123456789/1324	-
dc.description.abstract	Background & Objectives: Despite decades of health programs, Iron Deficiency Anemia continues to be a major problem during pregnancy. Due to proven poor compliance with oral iron and multi-dosing with older parenteral iron, single dose Parental iron is preferred. In India two single dose IV iron preparations (IIM and FCM) are available. This study aims to evaluate the efficacy and safety (rise in Hemoglobin) of Inj. Iron Isomaltoside in comparison to Inj. Ferric Carboxymaltose in treating Iron deficiency anemia in pregnancy.	en_US
dc.language.iso	en_US	en_US
dc.publisher	KLE Academy of Higher Education and Research, Belagavi	en_US
dc.subject	Iron isomaltoside, Ferric Carboxymaltose , Ferric derisomaltose, Anemia, Pregnancy	en_US
dc.title	Inj. Ferric carboxymaltose (fcm) vs iron Isomaltoside (iim) in anemia in pregnancy (antenatal) - a randomized controlled trial	en_US
dc.type	Dissertations	en_US
Appears in Collections:	Obstetrics & Gynaecology MS

Files in This Item:

File	Description	Size	Format
REG NO. BJ0119006.pdf		5.82 MB	Adobe PDF	View/Open